Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Randomized Clinical Trial of Selinexor Plus Gemcitabine in Selected Advanced Soft-tissue Sarcomas

NCT06114004 is registered in ClinicalTrials.gov with Asociación Europea y Latinoamericana SELNET para la Investigación en Sarcomas as lead sponsor.

NCT NCT06114004
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06114004 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Randomized Clinical Trial of Selinexor Plus Gemcitabine in Selected Advanced Soft-tissue Sarcomas
Lead sponsor
Asociación Europea y Latinoamericana SELNET para la Investigación en Sarcomas
Phase
Phase 2
Overall status
Recruiting
Start date
September 28, 2023
Completion date
May 31, 2026
Enrollment
88 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

sarcoma,soft tissue